期刊文献+

重组马立克病病毒CVI988/Rispens的构建 被引量:3

Construction of recombinant Marek's disease virus vaccine strain CVI988/Rispens
下载PDF
导出
摘要 根据I型马立克病病毒(MDV)强毒GA株基因序列,设计两对引物,用PCR方法扩增出CVI988/Rispens株的US10及其侧翼序列,分别克隆入pUC18载体中。经测序检测正确后,进一步插入含CMV启动子的绿色荧光蛋白 (EGFP)基因表达盒,获得了含EGFP报告基因的转移载体质粒pPUC18-US10-EGFP。通过同源重组,成功地筛选出表达EGFP的重组病毒rCVI988-EGFP,经传代证明重组rCVI988-EGFP在感染的CEF细胞中能稳定表达EGFP。结果表明:构建的重组转移载体质粒正确,US10是MDV复制非必需片段,为进一步利用US10区构建重组MDV多价基因工程疫苗奠定了基础。 The US10 and its flanks of CV1988/Rispens strain were amplified by PCR with primers designated according to the sequence of “virulent” GA strain of Marek's disease virus (MDV) serotype I and subcloned into pUC18 plasmid, named as pUC-US10. The expression cassette including EGFP gene controlled by CMV promoter and the enhancer was then cloned into pUC-US10 vector as a marker of the transfer vector pUC18-US10-EGFP. A stable recombinant Marek's disease virus (rMDV) expressing EGFP was obtained by homologous recombination with virus of CVI988/Rispens strain in CEF. These results proved that the US10 of MDV is one of non-essential sites in the viral genome for viral growth in vitro. It facilities the construction of recombinant MDV expressing foreign genes in future.
出处 《扬州大学学报(农业与生命科学版)》 CAS CSCD 北大核心 2005年第4期1-4,共4页 Journal of Yangzhou University:Agricultural and Life Science Edition
基金 国家高技术研究发展计划项目(863-2002AA245051)全国博士学位论文作者专项资金(200256)
关键词 马立克病病毒 绿色荧光蛋白 载体构建 重组病毒 Marek' s disease virus EGFP transfer vector recombinant virus
  • 相关文献

参考文献14

  • 1周蛟,周煜,林健.CVI988/Rispens疫苗的过去、现在和未来[J].养禽与禽病防治,2001(8):10-11. 被引量:2
  • 2Cantello J L, Anderson A S, Francesconi A, et al. Isolation of a Marek's disease virus (MDV) recombinant containing the lacZ gene of Escherichia coli stably inserted within the MDV US2 gene [J]. J Virol, 1991, 65:1584-1588. 被引量:1
  • 3Parcells M S, Anderson A S, Morgan R W, et al. Characterization of a Marek's disease virus mutant containing a lacZ insertion in the US6 (gD) homologue gene [J]. Virus Genes, 1994, 9: 5-13. 被引量:1
  • 4Parcells, M S, Anderson A S, Morgan T W, et al. Retention of oncogenicity by a Marek's disease virus mutant lacking six unique short region genes [J]. J Virol, 1995, 69: 788-789. 被引量:1
  • 5Sakaguchi M, Hirayama Y, Maeda H, et al. Construction of recombinant Marek's disease virus type 1 (MDV1)expressing the Escherichia coli lacZ gene as a possible live vaccine vector: the US10 gene of MDV1 as a stable insertion site [J]. Vaccine, 1994, 12: 953-957. 被引量:1
  • 6Sakaguchi M, Urakawa T, Hirayama Y, et al. Sequence determination and genetic content of an 8.9 kb restriction fragment in the short unique region and the internal inverted repeat of Marek's disease virus type 1 DNA [J].Virus Genes, 1992, 6: 365-378. 被引量:1
  • 7Sakaguchi M, Urakawa T, Hirayama Y, et al. Marek's disease virus protein kinase gene identified within the short unique region of the viral genome is not essential for viral replication in cell culture and vaccine-induced immunity in chickens [J]. Virology, 1993, 195: 140-148. 被引量:1
  • 8Sonoda K, Sakaguchi M, Matsuo K, et al. Asymmetric deletion of the junction between the short unique region and the inverted repeat does not affect viral growth in culture and vaccine-induced immunity against Marek's disease [J]. Vaccine, 1996, 14:277-284. 被引量:1
  • 9Sakaguchi M, Nakamura H, Sonoda K, et al. Protection of chickens from Newcastle disease by vaccination with a linear plasmid DNA expressing the F protein of Newcastle disease virus [J]. Vaccine, 1996, 14:747-752. 被引量:1
  • 10Sakaguchi M, Nakamura H, Sonoda K, et al. Protection of chickens with or without maternal antibodies against both Marek's and Newcastle diseases by one-time vaccination with recombinant vaccine of Marek's disease virus type 1 [J]. Vaccine, 1998, 16: 472-479. 被引量:1

二级参考文献24

  • 1崔治中 孙怀昌 等.禽白血病及禽网状内皮增生病感染情况的调查[J].中国畜禽传染病,1987,(1):37-38. 被引量:17
  • 2萨姆布鲁克J 弗里奇EF 曼尼阿蒂斯T著.金冬雁 黎孟枫 译.分子克隆实验指南[M].第2版[M].北京:科学出版社,1992.456-494. 被引量:22
  • 3Witter R L. Reticuloendotheliosis [A]. Calnek B W, Barmes M S, Witter R L, et al. Diseases of poultry [C].10th ed. Ames: Iowa State University Press, 1997. 467-484. 被引量:1
  • 4Calvert J G, Nazerian K, Witter R L, et al. Fowlpox virus recombinants expressing the envelope glycoprotin of an avian reticuloendotheliosis retrovirusinduce neutralizing antibodies and reduce viremia in chickens[J]. J Virol,1993, 67(6): 3069-3076. 被引量:1
  • 5Delwart E L, Panganiban A T. Role of reticuloendotheliosis virus envelope glycoprotein in superinfection interference [J]. J Virol, 1989, 63(1): 273-280. 被引量:1
  • 6Federspiel M J, Crittenden L B, Hughes H. Expression of avain reticuloendotheliosis virus confers host resistance [J]. Virology, 1989, 173: 161-177. 被引量:1
  • 7Dorange F, E1 Mehdaoui S, Pichon C, et al. Marek's disease virus (MDV) homologues of herpes simplex virus type 1 UL49 (VP22) and UL48 (VP16) genes: high-level expression and characterization of MDV-1 VP22 and VP16 [J]. J Gen Virol, 2000, 81(9):2219-2230. 被引量:1
  • 8Yanagida N, Yoshida S, Nazerian K, et al. Nucleotide and predicted amino acid sequences of Marek's disease virus homologues of herpes simplex virus major tegument proteins [J]. J Gen Virol, 1993, 74(9): 1837-1845. 被引量:1
  • 9Elliott G D, Meredith D M. The herpes simplex virus type 1 tegument protein VP22 is encoded by gene UL49[J]. J Gen Virol, 1992, 73(3): 723-726. 被引量:1
  • 10Hung C F, He L, Juang J, et al. Improving DNA vaccine potency by linking Marek's disease virus type 1 VP22 to an antigen [J]. J Virol, 2002, 76(6): 2676-2682. 被引量:1

共引文献7

同被引文献42

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部